Skip to main content
. Author manuscript; available in PMC: 2011 Jan 28.
Published in final edited form as: J Med Chem. 2010 Jan 28;53(2):876–886. doi: 10.1021/jm900556s

Table 1.

9L cell uptake of (R)- and (S)-[18F]5 and (R)- and (S)-[18F]8 at 30 minutes incubation with or without inhibitors.

Control BCH MeAIB ACS
(R)-FAMP 5 uptake 13.06±0.23 4.27±0.21 5.51±0.16 1.70±0.02
inhibition 67.34 57.79 86.98
p <0.0001 <0.0001 <0.0001
(S)-FAMP 5 uptake 4.77±0.73 1.21±0.13 3.29±0.15 1.33±0.27
inhibition 74.66 30.93 72.18
p <0.002 <0.03 <0.002
(R)-NMeFAMP 8 uptake 7.08±0.47 3.26±0.22 0.60±0.12 0.75±0.09
inhibition 53.93 91.59 89.42
p <0.0001 <0.0001 <0.0001
(S)-NMeFAMP 8 uptake 3.87±0.22 2.76±0.20 0.82±0.11 1.62±0.08
inhibition 28.7 78.89 58.15
p <0.002 <0.0001 <0.0001

Values are reported as percent uptake of the initial dose per 0.5 million cells (% ID/5×105 cells) ± standard deviation (SD) (n=3).

Inhibition is expressed as percent relative to control (%).

p values represent comparisons of uptake with inhibitors to control uptake for each radiotracer using one-way ANOVA tests.